Diagnostics and Personalized Medicine Conference

Biological understanding of disease and technological advances in diagnostic testing have increased dramatically in recent years making possible huge advances that can drive the targeting of treatments to the patients most likely to benefit. While precision medicine has seen the biggest advances in oncology, these developments will serve to facilitate the uptake of biomarker use and potential companion diagnostic development in disease areas outside oncology. Given this, our industry is faced with the exciting opportunities of advancing these precision medicines while navigating the challenges associated with implementing this in therapeutic indications where biomarker testing for treatment decision making is less well established. In this session, we will look at the advances in precision medicine in some of these key therapeutic indications while discussing the opportunities and challenges we face in making this a reality. Specifically, the session will…

• Outline advances in precision medicine thinking
• Discuss the current and future regulatory landscape for precision medicines in the non-oncology setting
• Discuss the opportunities and challenges of driving precision medicine in these settings